A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1

Por Allen, Allison J, Ali, Siraj M., Gowen, Kyle, Elvin, Julia A., Pejovic, Tanja
Publicado no Gynecol Oncol Rep (2017)

Successful treatment of a patient with Li–Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with...

Por Jia, Yuxia, Ali, Siraj M, Saad, Shumaila, Chan, Courtney A, Miller, Vincent A, Halmos, Balazs
Publicado em 2014

Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: a case report

Por Bhangoo, Munveer S., Zhou, Jenny Y., Ali, Siraj M., Madison, Russell, Schrock, Alexa B., Costantini, Carrie
Publicado no BMC Cancer (2017)

A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer Patient

Por Ali, Siraj M., Watson, Jessica, Wang, Kai, Chung, Jon H., McMahon, Caitlin, Ross, Jeffrey S., Dicke, Karel A.
Publicado no Case Rep Oncol (2016)

Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus

Por West, Allison H., Yamada, S. Diane, MacMahon, Heber, Acharya, Sheetal S., Ali, Siraj M., He, Jie, Lukas, Rimas V., Miller, Vincent A., Salgia, Ravi
Publicado no Case Rep Clin Pathol (2014)

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

Por Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Publicado em 2014

FGFR3–TACC3: A novel gene fusion in cervical cancer

Por Carneiro, Benedito A., Elvin, Julia A., Kamath, Suneel D., Ali, Siraj M., Paintal, Ajit S., Restrepo, Alvaro, Berry, Emily, Giles, Francis J., Johnson, Melissa L.
Publicado no Gynecol Oncol Rep (2015)

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

Por Subbiah, Vivek, Westin, Shannon N, Wang, Kai, Araujo, Dejka, Wang, Wei-Lien, Miller, Vincent A, Ross, Jeffrey S, Stephens, Phillip J, Palmer, Gary A, Ali, Siraj M
Publicado em 2014

Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative

Por Lim, Sun Min, Kim, Eun Young, Kim, Hye Ryun, Ali, Siraj M., Greenbowe, Joel R., Shim, Hyo Sup, Chang, Hyun, Lim, Seungtaek, Paik, Soonmyung, Cho, Byoung Chul
Publicado no Oncotarget (2016)

Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin

Por Chmielecki, Juliann, Ross, Jeffrey S., Wang, Kai, Frampton, Garrett M., Palmer, Gary A., Ali, Siraj M., Palma, Norma, Morosini, Deborah, Miller, Vincent A., Yelensky, Roman, Lipson, Doron, Stephens, Philip J.
Publicado no Oncologist (2015)

Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged Non-Small Cell Lung Cancer with brain metastases

Por Subbiah, Vivek, Berry, Jenny, Roxas, Michael, Guha-Thakurta, Nandita, Subbiah, Ishwaria Mohan, Ali, Siraj M., McMahon, Caitlin, Miller, Vincent, Cascone, Tina, Pai, Shobha, Tang, Zhenya, Heymach, John V.
Publicado no Lung Cancer (2015)

Identification and characterization of RET fusions in advanced colorectal cancer

Por Le Rolle, Anne-France, Klempner, Samuel J., Garrett, Christopher R., Seery, Tara, Sanford, Eric M., Balasubramanian, Sohail, Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Ali, Siraj M., Chiu, Vi K.
Publicado no Oncotarget (2015)

A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib

Por Chung, Jon H., Ali, Siraj M., Davis, Jenni, Robstad, Karl, McNally, Richard, Gay, Laurie M., Erlich, Rachel L., Palma, Norma A., Stephens, Phil J., Miller, Vincent A., Cutugno, Alfonso, Ross, Jeffrey S.
Publicado em 2014

Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy

Por Ali, Siraj M., Alpaugh, R. Katherine, Downing, Sean R., Stephens, Philip J., Yu, Jian Q., Wu, Hong, Buell, Jamie K., Miller, Vincent A., Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Cristofanilli, Massimo
Publicado no J Clin Oncol (2014)

Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers

Por Weinberg, Benjamin A., Gowen, Kyle, Lee, Thomas K., Ou, Sai‐Hong Ignatius, Bristow, Robert, Krill, Lauren, Almira‐Suarez, M. Isabel, Ali, Siraj M., Miller, Vincent A., Liu, Stephen V., Klempner, Samuel J.
Publicado no Oncologist (2017)

Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer

Por Rankin, Andrew, Klempner, Samuel J., Erlich, Rachel, Sun, James X., Grothey, Axel, Fakih, Marwan, George, Thomas J., Lee, Jeeyun, Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Ali, Siraj M., Schrock, Alexa B.
Publicado no Oncologist (2016)

Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary

Por Palma, Norma A., Ali, Siraj M., O'Connor, Jamie, Dutta, Deepa, Wang, Kai, Soman, Salil, Palmer, Gary A., Morosini, Deborah, Ross, Jeffrey S., Lipson, Doron, Stephens, Phil J., Patel, Mayur, Miller, Vincent A., Koutrelakos, Nicholas
Publicado em 2014

GE-04 COMPREHENSIVE GENOMIC PROFILING (CGP) OF PEDIATRIC GLIOMAS REVEALS A HIGH FREQUENCY OF CLINICALLY RELEVANT GENOMIC ALTERATIONS (CRGA) ASSOCIATED WITH BENEFIT FROM TARGETED TH...

Por Chalmers, Zachary R., Ali, Siraj M., Frampton, Garrett M., Chmielecki, Juliann, Palma, Norma A., Elvin, Julia A., Johnson, Adrienne, Yelensky, Roman, Ross, Jeffery S., Stephens, Phillip J., Miller, Vincent A., Waanders, Angela J., Crawford, John
Publicado no Neuro Oncol (2015)

Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences

Por Wang, Kai, Johnson, Adrienne, Ali, Siraj M., Klempner, Samuel J., Bekaii-Saab, Tanios, Vacirca, Jeffrey L., Khaira, Depinder, Yelensky, Roman, Chmielecki, Juliann, Elvin, Julia A., Lipson, Doron, Miller, Vincent A., Stephens, Philip J., Ross, Jeffrey S.
Publicado no Oncologist (2015)

BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

Por Klempner, Samuel J., Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K., Erlander, Mark G., Gowen, Kyle, Schrock, Alexa B., Morosini, Deborah, Ross, Jeffrey S., Miller, Vincent A., Stephens, Philip J., Ignatius Ou, Sai-Hong, Ali, Siraj M.
Publicado no Cancer Discov (2016)